IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Materia Secures NIH Funding to Develop Alternative Reagents

5:22 AM MDT | May 1, 2012 | Alex Scott

Materia (Pasadena, CA), a catalyst firm with an exclusive license for Grubbs catalyst technology, has received a Phase II Fast Track Small Business Technology Transfer grant from the National Institutes of Health (NIH) for the continued development of functional polymers for use in organic synthesis in pharmaceutical applications.   The money will go toward the development of Materia’s methesis catalyst system applied to the development and scale-up of reagents for use in drug discovery. The technology has the potential for providing a series of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa